Understanding the WISeR Pilot Program
The Centers for Medicare & Medicaid Services (CMS) has announced a groundbreaking pilot program that will fundamentally change how Medicare patients receive approval for certain medical procedures. The WISeR program—which stands for “Wasteful and Inappropriate Service Reduction”—represents Medicare’s first major foray into using artificial intelligence algorithms for prior authorization decisions.
Starting January 1, 2025, and continuing through 2031, doctors and hospitals will need to seek insurance approval before proceeding with specific procedures, tests, and prescriptions for their Medicare patients. This marks a significant departure from traditional Medicare practices, which have historically avoided the prior authorization requirements common in private insurance markets.
What Prior Authorization Means for Patients
Prior authorization is a process where healthcare providers must obtain approval from insurance companies before delivering certain medical services. While this practice has been standard in Medicare Advantage plans and private insurance, traditional Medicare has largely operated without these restrictions, allowing doctors greater autonomy in treatment decisions.
The federal government justifies this new approach by arguing that certain procedures are particularly vulnerable to “fraud, waste, and abuse” and could be held in check through AI-powered prior authorization systems.
Which States and Procedures Are Affected
The WISeR pilot will initially impact Medicare patients in six states: Arizona, Ohio, Oklahoma, New Jersey, Texas, and Washington. These states were selected to test the effectiveness of AI-driven prior authorization across diverse healthcare markets and patient populations.
Targeted Medical Procedures
The pilot program will initially focus on several specific types of medical services:
- Skin and tissue substitutes used in wound care and reconstructive procedures
- Electrical nerve stimulator implants for chronic pain management
- Knee arthroscopy procedures for joint problems
CMS has indicated that additional procedures may be added to the list as the program evolves. However, the agency has promised that certain categories of care will remain exempt from AI review, including emergency services, inpatient-only procedures, and any treatments where significant delays would pose substantial health risks to patients.
The Contradiction in Trump Administration Policy
The timing and nature of the WISeR pilot has raised significant concerns among healthcare policy experts, lawmakers, and patient advocates. Just days before announcing this Medicare expansion, the Trump administration unveiled a voluntary initiative encouraging private health insurers to reduce their use of prior authorization.
Mixed Messages from Federal Leadership
During a June press conference, CMS Administrator Mehmet Oz strongly criticized prior authorization practices in the private insurance industry, stating that the process causes care to be “significantly delayed” and “erodes public trust in the health care system.” Oz emphasized that such delays were “something that we can’t tolerate in this administration.”
Dr. Vinay Rathi, an Ohio State University doctor and policy researcher, has accused the administration of sending contradictory signals. “On one hand, the federal government wants to borrow cost-cutting measures used by private insurance,” he explained. “On the other, it slaps them on the wrist.”
Representative Suzan DelBene, a Washington Democrat, expressed similar concerns about the policy inconsistency. Administration officials are “talking out of both sides of their mouth,” she said. “It’s hugely concerning.”
The Violence Reference
Notably, Administrator Oz mentioned during his June press conference that “violence in the streets” prompted the Trump administration to address prior authorization reform in private insurance—a likely reference to high-profile incidents targeting health insurance executives. Yet simultaneously, the administration is expanding these same practices within Medicare.
CMS spokesperson Alexx Pons defended the dual approach, stating that both initiatives “serve the same goal of protecting patients and Medicare dollars.”
How AI Will Make Authorization Decisions
While artificial intelligence in health insurance isn’t entirely new, Medicare’s adoption of these private-sector tools represents a significant policy shift. The WISeR program will employ AI algorithms to evaluate whether requested medical procedures meet Medicare’s criteria for coverage.
Human Review Safeguards
According to CMS, no Medicare request will be denied before review by a “qualified human clinician.” The agency has also stated that vendors participating in the program “are prohibited from compensation arrangements tied to denial rates.”
Pons emphasized that multiple safeguards will “remove any incentive to deny medically appropriate care.” The use of AI in the Medicare pilot will be “subject to strict oversight to ensure transparency, accountability, and alignment with Medicare rules and patient protection,” he said.
The Shared Savings Model
However, the program’s structure has raised red flags among healthcare experts. Under the shared savings arrangement, vendors will be financially rewarded when costs are reduced. Critics argue that “shared savings arrangements mean that vendors financially benefit when less care is delivered,” creating powerful incentives for companies to deny medically necessary care.
Concerns About AI-Driven Care Denials
Healthcare advocates, patients, and medical professionals have expressed serious concerns about what they characterize as delay-or-deny tactics enabled by AI systems. These practices can slow down or completely block access to necessary care, potentially causing irreparable harm or even death.
The Speed of AI Reviews
Representative Greg Murphy, a North Carolina Republican and physician, noted that insurance companies have adopted a “mantra that they will take patients’ money and then do their damnedest to deny giving it to the people who deliver care.”
Research has raised questions about the thoroughness of AI-assisted reviews. A 2023 ProPublica investigation found that doctors at Cigna reviewing payment requests spent an average of only 1.2 seconds per case over a two-month period. While Cigna spokesperson Justine Sessions denied that the company uses AI to deny care, the investigation highlighted concerns about the adequacy of human oversight.
Legal Challenges
Class-action lawsuits filed against major health insurers have alleged that flawed AI models undermine doctor recommendations and fail to consider patients’ unique medical needs. These lawsuits claim that algorithmic decision-making forces some patients to shoulder the financial burden of their care when coverage is improperly denied.
What Experts Are Saying
Healthcare policy researchers remain skeptical about the WISeR pilot’s implementation and potential outcomes.
Amy Killelea, an assistant research professor at Georgetown University’s Center on Health Insurance Reforms, raised questions about what constitutes meaningful human review of AI decisions. “I think that there’s also probably a little bit of ambiguity over what constitutes ‘meaningful human review,'” she said.
The High-Cost Care Problem
Professor Jennifer Oliva from Indiana University-Bloomington’s Maurer School of Law, whose work focuses on AI regulation and health coverage, explained that algorithms may be programmed to automatically deny expensive treatments. “The more expensive it is, the more likely it is to be denied,” she said.
Oliva’s research suggests that when patients are expected to have shorter life expectancies, health insurers become “motivated to rely on the algorithm.” As appeals drag on, the likelihood of the patient dying during the process increases, reducing the insurer’s financial liability. “The No. 1 thing to do is make it very, very difficult for people to get high-cost services,” she explained.
Regulatory Blind Spot
Carmel Shachar, a faculty director at Harvard Law School’s Center for Health Law and Policy Innovation, characterized insurance company algorithms as a “regulatory blind spot” demanding greater scrutiny. While she sees the WISeR pilot as “an interesting step” toward ensuring Medicare dollars purchase high-quality care, the lack of detailed information makes it difficult to assess whether the program will succeed.
The Future of AI in Medicare
Politicians and healthcare advocates continue to grapple with fundamental questions about the WISeR pilot program’s implementation and oversight.
Representative DelBene has pressed for answers: “How is this being tested in the first place? How are you going to make sure that it is working and not denying care or producing higher rates of care denial?” She and other lawmakers signed an August letter to the Department of Health and Human Services demanding more transparency.
A Wait-and-See Approach
Representative Murphy acknowledged that AI in healthcare is inevitable but expressed reservations about whether the WISeR pilot will achieve its stated goals. “This is a pilot, and I’m open to see what’s going to happen with this,” Murphy said, “but I will always, always err on the side that doctors know what’s best for their patients.”
Dr. Rathi expressed uncertainty about the program’s evaluation metrics, stating, “I’m not sure they know, even, how they’re going to figure out whether this is helping or hurting patients.”
Patient Advocacy
As the January 2025 launch date approaches, patient advocacy groups are mobilizing to monitor the program’s impact on healthcare access and quality. Medicare beneficiaries in the six pilot states should stay informed about which procedures require prior authorization and understand their appeal rights if coverage is denied.
The success or failure of the WISeR pilot could have far-reaching implications for the future of Medicare and the role of artificial intelligence in healthcare decision-making across the United States.
Discover the latest GovHealth news updates with a single click. Follow DistilINFO GovHealth and stay ahead with updates. Join our community today!
